Login / Signup

Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?

Carleigh DukeSuzanne L ParkerBetty B ZamFabian ChiongCherian SajivBasant PawarAadith AshokBrynley P CooperSteven Y C TongSonja JansonSteven C WallisJason Alexander RobertsDanny Tsai
Published in: The Journal of antimicrobial chemotherapy (2024)
A 2 g three-times-weekly post-dialysis cefazolin regimen is supported for MSSA infections.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • high intensity
  • combination therapy